Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 17 points (-0.1%) at 17,039 as of Tuesday, July 15, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 915 issues advancing vs. 2,069 declining with 174 unchanged. The Health Services industry currently sits down 0.8% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Accelerate Diagnostics ( AXDX), down 9.4%, Boston Scientific ( BSX), down 2.7%, Stryker Corporation ( SYK), down 1.3% and Abbott Laboratories ( ABT), down 1.2%. A company within the industry that increased today was Edwards Lifesciences ( EW), up 0.6%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Agilent Technologies ( A) is one of the companies pushing the Health Services industry lower today. As of noon trading, Agilent Technologies is down $0.48 (-0.8%) to $56.34 on average volume. Thus far, 870,389 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $56.15-$56.88 after having opened the day at $56.70 as compared to the previous trading day's close of $56.82. Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $18.9 billion and is part of the health care sector. Shares are down 1.0% year-to-date as of the close of trading on Monday. Currently there are 9 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold. TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.